Labcorp Holdings (LH) EVP Amy Summy sells 924 common shares

Rhea-AI Filing Summary

Amy B. Summy, EVP and Chief Marketing Officer of Labcorp Holdings Inc., reported a sale of 924.0000 shares of Common Stock on 2026-08-04 at $306.7400 per share in a sale classified as an open-market or private transaction. After this sale, she directly owns 6955.5000 shares.

Insider Trade Summary

Net Seller: 924 shares

Net Sell 1 txn

Insider Summy Amy B.

Role EVP, Chief Marketing Officer

Sold 924 shs ($283K)

Type	Security	Shares	Price	Value
Sale	Common Stock	924	$306.74	$283K

Holdings After Transaction: Common Stock — 6,955.5 shares (Direct)

Key Figures

Shares sold: 924.0000 shares Sale price: $306.7400 per share Shares owned after sale: 6955.5000 shares

3 metrics

Shares sold 924.0000 shares Common Stock sale on 2026-08-04

Sale price $306.7400 per share Sale in open market or private transaction

Shares owned after sale 6955.5000 shares Direct ownership following reported transaction

Key Terms

Common Stock, Sale in open market or private transaction, Form 4

3 terms

Common Stock financial

"security_title: "Common Stock" for the reported transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Sale in open market or private transaction financial

"transaction_code_description: "Sale in open market or private transaction""

Form 4 regulatory

"Insider equity transaction reported on SEC Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 08:26 AM Accepted by SEC EDGAR 08/06/2026 - 08:26 AM Learn about SEC filing dates

FAQ

What insider transaction did Amy B. Summy report for Labcorp (LH)?

Amy B. Summy, EVP and Chief Marketing Officer of Labcorp, reported selling 924.0000 Common Stock shares on 2026-08-04 at $306.7400 per share. The transaction is coded as a sale in an open-market or private transaction on SEC Form 4.

At what price were Amy B. Summy’s Labcorp (LH) shares sold in this Form 4?

The reported Labcorp shares were sold at $306.7400 per share. The Form 4 describes the transaction as a sale in an open-market or private transaction involving 924.0000 shares of Labcorp Holdings Inc. Common Stock.

How many Labcorp (LH) shares does Amy B. Summy hold after this reported sale?

Following the transaction, Amy B. Summy directly holds 6955.5000 shares of Labcorp Common Stock. This post-transaction ownership figure is reported in the Form 4 as the total shares directly owned after the 924.0000-share sale.

Was Amy B. Summy’s Labcorp (LH) stock sale under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not selected. The document-level indicator aff_10b5_one is false, meaning the Form 4 does not affirm that the reported 924.0000-share sale was executed under a Rule 10b5-1 trading plan.

What position does Amy B. Summy hold at Labcorp (LH) in this Form 4?

Amy B. Summy is identified as EVP, Chief Marketing Officer of Labcorp Holdings Inc. in the Form 4. She is reported as an officer of the company and not as a director or ten percent beneficial owner.

What type of security was involved in Amy B. Summy’s Labcorp (LH) transaction?

The transaction involved Common Stock of Labcorp Holdings Inc. It is reported as a non-derivative transaction in the Form 4, with no accompanying derivative security exercises or conversions disclosed in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Summy Amy B.

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NORTH CAROLINA 27215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Marketing Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2026		S		924	D	$306.74	6,955.5	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Amy B. Summy	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)